Medline targets $55bn valuation in mega PE-backed IPO
Medline, the medical supply manufacturer backed by Blackstone, Carlyle, and Hellman & Friedman, is targeting a $55bn valuation in a US IPO which would make it one of the largest PE-backed listings ever, according to a report by Reuters.